Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study.
Journal: The British journal of dermatology
Published: October 20, 2022
Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b, randomized, double-blind, placebo-controlled study.
Journal: Journal of the American Academy of Dermatology
Published: November 12, 2021
Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomized, double-blind, vehicle-controlled, dose-ranging and parallel-group study.
Journal: The British journal of dermatology
Published: August 24, 2021
Safety, Tolerability, and Pharmacokinetics of PF-06823859, an Anti-Interferon β Monoclonal Antibody: A Randomized, Phase I, Single- and Multiple-Ascending-Dose Study.
Journal: Clinical pharmacology in drug development
Published: March 12, 2020
Phase I Pharmacokinetic Study of Fixed-Dose Combinations of Ibuprofen and Acetaminophen in Healthy Adult and Adolescent Populations.
Journal: Drugs in R&D
Published: March 05, 2020
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver-Targeting Acetyl-CoA Carboxylase Inhibitor (PF-05221304): A Three-Part Randomized Phase 1 Study.
Journal: Clinical pharmacology in drug development
Published: July 02, 2019
Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults.
Journal: Vaccine
Published: March 06, 2019
Evaluation of a Janus kinase 1 inhibitor, PF-04965842, in healthy subjects: A phase 1, randomized, placebo-controlled, dose-escalation study.
Journal: British journal of clinical pharmacology
Published: December 13, 2017
Safety, Pharmacokinetic, and Pharmacodynamic Evaluation After Single and Multiple Ascending Doses of a Novel Selective Androgen Receptor Modulator in Healthy Subjects.
Journal: Clinical therapeutics
Published: December 25, 2015
First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 22, 2015
Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia.
Journal: Science translational medicine
Published: October 29, 2015
Last Updated: 09/26/2026